Posch 2022 MitoFit
|Posch W, Dichtl S, Zaderer V, Lass-Flörl C, Wilflingseder D (2022) How to optimize respiratory models for SARS-CoV-2 research. https://doi.org/10.26124/mitofit:2022-0004 — 2022-09-08 published in Bioenerg Commun 2022.9.|
» MitoFit Preprints 2022.04.
How to optimize respiratory models for SARS-CoV-2 research
Posch Wilfried, Dichtl Stefanie, Zaderer Viktoria, Lass-Floerl Cornelia, Wilflingseder Doris (2022) MitoFit Prep
Wilflingseder 2022 Abstract Bioblast: Sophisticated 3D cell culture tissue models experienced a boom in the last years and in particular human cell culture and 3D respiratory systems greatly supported the development of novel drugs and vaccines during the SARS-CoV-2 pandemic lately. These models provide multiple benefits in terms of similarities in differentiation, metabolism, receptor expression, polarity, infectivity compared to human tissues and thus provide excellent models to study very first interactions with the host during pathogen entry. Dependent on the experimental approach, the use of different 3D models is more beneficial – apical out lung organoids for e.g., high content screening (HCS) of treatment options, air-liquid interphase (ALI) models for e.g., easy incorporation of immune cells, screening of epithelial integrity or mucociliary clearance. This review will give an overview on the models established in our laboratory and on their applications.
• Keywords: respiratory models, air-liquid interphase, SARS-CoV-2 • Bioblast editor: Tindle-Solomon L
ORCID: Posch Wilfried, Dichtl Stefanie, Zaderer Viktoria, Lass-Flörl Cornelia, Wilflingseder Doris
Labels: Pathology: Infectious
Organism: Human Tissue;cell: Lung;gill, Endothelial;epithelial;mesothelial cell, Lymphocyte